Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0024530 (malaria)
 44,886 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Emerging and reemerging infections are attracting greater attention from the public health and medical communities. Pathologists and other physicians are increasingly aware of the importance of the subspecialty of infectious disease pathology as a tool for diagnosis, surveillance, and research of emerging infections. In this communication, we describe the role that infectious disease pathologists have played during the last 2 years in broadening our understanding of selected emerging infections, including such examples as new variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy, leptospirosis, microsporidiosis, Ebola hemorrhagic fever, and cyclosporiasis. The significance of providing pathology services, especially the autopsy, to patients with potentially hazardous communicable diseases is discussed with the supposition that it is unethical to exclude or withhold health care from a patient based on his or her underlying disease or on risk factors for acquiring a disease. The increasing occurrence of infectious diseases imported into the United States and other nations, including human immunodeficiency virus-1 group O, dengue fever, tuberculosis, malaria, diphtheria and cholera in immigrants and travelers, and Ebola virus in nonhuman primates, emphasizes the necessity for pathologists of having competence with infectious disease pathology. It is critical that new generations of pathologists not only be trained in the subspecialty of infectious disease pathology, but that they also be willing participants in the diagnosis and investigation of infectious diseases. The lack of training programs for infectious disease pathologists, as well as the deficiency in infectious disease pathology support for ongoing and future epidemiologic investigations and research, has led to the broadening of pathology services and initiation of a dedicated section of Infectious Disease Pathology at one of the nation's premier public health institutions, the Centers for Disease Control and Prevention in Atlanta, Ga. Together with preexisting groups of medical and veterinary infectious disease pathologists at universities, the Armed Forces Institute of Pathology, the US Army Medical Research Institute of Infectious Diseases, and the National Institutes of Health, this new program will significantly strengthen the capability of the United States to respond to future challenges of emerging and reemerging infections, both in this country and abroad.
 ...
PMID:Emerging and reemerging infections. Progress and challenges in the subspecialty of infectious disease pathology. 927 4

Various measures are taken to ensure the safety of the blood supply. Donor selection begins with education of the public about transfusion-transmissible diseases. Potential donors must answer a questionnaire designed to identify specific risk factors for these infections. The questionnaire is the only line of protection against certain infections for which no testing is performed, such as malaria, babesiosis, leishmaniasis, and Chagas disease. All donations are tested for the presence of antibodies to HIV-1 and -2, HCV, HTLV and syphilis, the hepatitis B surface antigen (HbsAg), the p24 antigen (HIV), and also for HIV and HCV nucleic acids. The introduction of new and improved screening tests for transfusion-transmissible diseases has led to remarkable improvement in the safety of the blood supply, with substantial shortening of the window period for HIV, HCV, and HBV infections. The current challenge of the industry is to reduce even further the small but significant risk of bacterial contamination of platelet components. Finally, some safety measures are purely precautionary, such as the deferral of donors who have traveled to certain countries affected by the bovine spongiform encephalopathy (BSE).
 ...
PMID:Blood donor selection and screening: strategies to reduce recipient risk. 1223 32

By reviewing the most significant zoonotic disease outbreaks that have occurred mostly during the past ten years, the author provides a clear idea of how varied these diseases can be in regard to their aetiological agent, size and direct impact on public health. Most examples involve emerging zoonotic diseases caused by viruses and prions and transmitted to humans by a bite, close contact with affected live animals or carcasses, or through the consumption of their tissues. These outbreaks vary from very small and localised clusters of individual cases to millions of deaths, as reported during the past influenza pandemics. The author also shows that even for the larger outbreaks, the direct impact on public health measured by the morbidity and mortality of zoonoses is largely inferior to that of major communicable diseases that affect only humans, particularly human tuberculosis, malaria, HIV/AIDS. However, it is very difficult to predict the outcome on public health of these emerging zoonotic diseases since transmission patterns are not always sufficiently understood to assess this impact accurately. In addition, new modes of agent transmission may compound the initial impact on public health. Finally, the author indicates additional reasons that explain why these diseases are important by placing special emphasis on the financial losses recorded in both human and animal health and also the societal non-monetary losses these diseases can incur. Lessons learnt following major crises generated by the emergence of zoonotic diseases, such as bovine spongiform encephalopathy, severe acute respiratory syndrome and avian influenza, are provided.
 ...
PMID:Impact of zoonoses on human health. 2042 71